National Institute of Allergy & Infectious Diseases

7-2-2020Next week, members of the HIV community from around the globe will gather virtually for the 23rd International AIDS Conference (AIDS 2020: Virtual) and, once a…

7-1-2020HIV.gov to host live conversation with federal and community EHE leaders at AIDS 2020.

5-18-2020NIAID honors ongoing efforts to develop a safe, effective and durable HIV vaccine while scientists also research coronavirus disease 2019 (COVID-19).

5-15-2020Cross-posted from NIAID NewsroomStudy Enrolling Adults with Mild to Moderate COVID-19 in the United States.Adults interested in participating in the trial shoul…

3-11-2020Cross-posted from NIAID NewsroomDolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.The antiretrov…

3-9-2020Cross-posted from NIAID NewsroomAmong African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenof…

3-9-2020Cross-posted from NIAID NewsroomThe cancer drug paclitaxel and a suppressive regimen of antiretroviral therapy (ART) is an effective treatment for AIDS-related …

3-9-2020Cross-posted from NIAID NewsroomA new approach to direct the body to make a specific antibody against HIV led to sustained production of that antibody for more …

3-4-2020HIV.gov will bring you live interviews on the latest developments in HIV research from CROI next week with NIH’s Dr. Carl Dieffenbach.

2-13-2020Cross-posted from NIAID NewsroomThe first clinical trial specifically designed to test the safety of the monthly dapivirine vaginal ring in pregnant women has …